Corrigendum to ‘Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells’ [Cancer letters, 2013, 330(1): 49–56](S0304383512006647)(10.1016/j.canlet.2012.11.017);Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells

Cancer Letters

Volumn 330, Issue 1, 2013, Pages 49-56

  Shao, Jingwei ^a   Dai, Yongchao ^a   Zhao, Wenna ^a   Xie, Jingjing ^a   Xue, Jinping ^a   Ye, Jianhui ^b   Jia, Lee ^a  

^a FUZHOU UNIVERSITY   (China)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Anticancer; Apoptosis; Photodynamic therapy; Photosensitizer; Reactive oxygen species; Zinc phthalocyanine

Indexed keywords

CASPASE 3; CASPASE 9; CREMOPHOR; PHTHALOCYANINE ZINC; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SOLUBILITY; DRUG TUMOR LEVEL; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; GROWTH CURVE; HUMAN; HUMAN CELL; IRRADIATION; LIVER CELL CARCINOMA; LYSOSOME; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL;

EID: 84872844266     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2018.03.001     Document Type: Erratum

References (35)

1. Robertson C.A., Evans D.H., Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J. Photochem. Photobiol. B 2009, 96:1-8.
2. Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3:380-387.
3. Oleinick N.L., Evans H.H. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 1998, 150:146-156.
4. Pass H.I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 1993, 85:443-456.
5. Schaffer M., Schaffer P., Corti L., Gardiman M., Sotti G., Hofstetter A. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model. J. Photochem. Photobiol. B 2002, 3:157-164.
6. MĹkvy P., Messmann H., Regula J., Conio M., Pauer M., Millson C. Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study. Neoplasma 1995, 42:109.
7. Xue L., Chiu S., Oleinick N.L. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 2001, 20:3420.
8. Huang J., Chen N., Liu E., Xue J., Yang S., Huang Z. Metal phthalocyanine as photosensitizer for photodynamic therapy (PDT). Sci. China Ser. B 2001, 44:113-122.
9. Agboola B., Ozoemena K.I., Nyokong T. Comparative efficiency of immobilized non-transition metal phthalocyanine photosensitizers for the visible light transformation of chlorophenols. J. Mol. Catal. A - Chem. 2006, 248:84-92.
10. Duro J.A., de la Torre G., Barbera J., Serrano J.L., Torres T. Synthesis and liquid-crystal behavior of metal-free and metal-containing phthalocyanines substituted with long-chain amide groups. Chem. Mater. 1996, 8:1061-1066.
11. Vol'pin M.E., Novodarova G.N., Krainova N.Y., Lapikova V.P., Aver'yanov A.A. Redox and fungicidal properties of phthalocyanine metal complexes as related to active oxygen. J. Inorg. Biochem. 2000, 81:285-292.
12. Allen C.M., Sharman W.M., Van Lier J.E. Current status of phthalocyanines in the photodynamic therapy of cancer. J. Porphyrins Phthalocyanines 2001, 5:161-169.
13. Mack J., Stillman M.J. Photochemical formation of the anion radical of zinc phthalocyanine and analysis of the absorption and magnetic circular dichroism spectral data. Assignment of the optical spectrum of [ZnPc (-3)]-. J. Am. Chem. Soc. 1994, 116:1292-1304.
14. Ochsner M. Light scattering of human skin: a comparison between zinc(II)-phthalocyanine and photofrin II. J. Photochem. Photobiol. B 1996, 32:3-9.
15. Nyokong T. Effects of substituents on the photochemical and photophysical properties of main group metal phthalocyanines. Coord. Chem. Rev. 2007, 251:1707-1722.
16. Zhang X., Xu H. Influence of halogenation and aggregation on photosensitizing properties of zinc phthalocyanine (ZnPc). J. Chem. Soc. Faraday Trans. 1993, 89:3347-3351.
17. 1 cell cycle arrest in cervical cancer cells. Biochem. Biophys. Res. Commun. 2006, 339:569-576.
18. Ishii K., Takayanagi A., Shimizu S., Abe H., Sogawa K., Kobayashi N. In vitro photodynamic effects of phthalocyaninatosilicon covalently linked to 2,2,6,6-tetramethyl-1-piperidinyloxy radicals on cancer cells. Free Radical Biol. Med. 2005, 38:920-927.
19. Oliveira D.M., Lacava Z.G.M., Lima E.C.D., Morais P.C., Tedesco A.C. Zinc phthalocyanine/magnetic fluid complex: a promising dual nanostructured system for cancer treatment. J. Nanosci. Nanotechnol. 2006, 6:2432-2437.
20. da Volta Soares M., dos Santos E.P., de Brito Gitirana L., Barbosa G.M., Quaresma C.H., Ricci-Júnior E. Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells. Int. J. Nanomed. 2011, 6:227-238.
21. Jia X., Jia L. Nanomaterials improve biological functions of photosensitizers used for photodynamic therapy. Curr. Drug Metab. 2012, 13:1119-1122.
22. Jia L., Garza M., Wong H., Reimer D., Redelmeier T., Camden J.B. Pharmacokinetic comparison of intravenous carbendazim and remote loaded carbendazim liposomes in nude mice. J. Pharm. Biomed. Anal. 2002, 28:65-72.
23. Shao J., Xue J., Dai Y., Liu H., Jia L., Chen N. Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest. Eur. J. Cancer 2012, 48:2086-2096.
24. Jia L., Schweizer J., Wang Y., Cerna C., Wong H., Revilla M. Effect of nitric oxide on cytotoxicity of Taxol: enhanced Taxol transcellular permeability. Biochem. Pharmacol. 2003, 66:2193-2199.
25. Cristobal J., Stockert J.C., Villanueva A., Rello-Varona S., Juarranz A., Canete M. Caspase-2: a possible trigger of apoptosis induced in A-549 tumor cells by ZnPc photodynamic treatment. Int. J. Oncol. 2006, 28:1057-1063.
26. Chang J.S., Noh D.Y., Park I.A., Kim M.J., Song H., Ryu S.H., Suh P.G. Overexpression of phospholipase C-gamma1 in rat 3Y1 fibroblast cells leads to malignant transformation. Cancer Res. 1997, 57:5465-5468.
27. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2005, 2:1-23.
28. Park J.B., Lee C.S., Jang J.H., Ghim J., Kim Y.J., You S., Hwang D., Suh P.G., Ryu S.H. Phospholipase signalling networks in cancer. Nat. Rev. Cancer 2012, 10.1038/nrc3379.
29. Moan J., Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 1991, 53:549-553.
30. Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3:380-387.
31. Steller H. Mechanisms and genes of cellular suicide. Science 1995, 267:1445-1449.
32. Degli Esposti M. Mitochondria in apoptosis: past, present and future. Biochem. Soc. Trans. 2004, 32:493-495.
33. Oleinick N.L., Morris R.L., Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 2002, 1:1-21.
34. Xia C., Wang Y., Chen W., Yu W., Wang B., Li T. New hydrophilic/lipophilic tetra-alpha-(4-carboxyphenoxy) phthalocyanine zinc-mediated photodynamic therapy inhibits the proliferation of human hepatocellular carcinoma Bel-7402 cells by triggering apoptosis and arresting cell cycle. Molecules 2011, 16:1389-1401.
35. Huang H., Zhao X., Chen Y., Lu R., Wu Y. Apoptosis induced by ZnPcH1-based photodynamic therapy in Jurkat cells and HEL cells. Int. J. Hematol. 2011, 94:539-544.